Thomas John Charles Insider Trades & Stock Holdings

EVP, General Counsel · Krystal Biotech, Inc. · Latest filing Jun 25, 2026

Thomas John Charles, EVP, General Counsel at Krystal Biotech, Inc. has 2 Form 4 trades on file since Jun 25, 2026. Latest filing: disposed of 1K shares of $KRYS on Jun 25, 2026.

Trades on file

2

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 25, 2026

All insider trades by Thomas John Charles

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$KRYS	Sell (Option exercise)	1K	$0	—			+4.2%	-2.3%		EVP, General Counsel		—
Jun 25, 2026	$KRYS	Buy (Option exercise)	1K	$179.25	$179.25K			+4.2%	-2.3%		EVP, General Counsel		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Thomas John Charles traded

• $KRYS

Frequently asked questions

What was Thomas John Charles's latest insider trade?

disposed of 1K shares of $KRYS on Jun 25, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.